Background: The Wessex AsThma CoHort of difficult asthma (WATCH) is a large prospective observational cohort study established at University Hospital Southampton (UHS) UK in 2015. Patients are enrolled from the UHS tertiary difficult asthma clinic. Aim: WATCH aims to improve understanding of the nature of difficult asthma in clinical practice. Here we report enrolment clinical characteristics. Methods: Patients undergo extensive clinical characterisation and phenotyping at enrolment using collated historical data plus objective clinical measurements. 380 patients have been enrolled to date with annual follow-up thereafter. Results: (as below) Conclusion: The cohort predominantly consists of female, middle-aged, atopic and obese patients who...
International audienceThe COhort of BRonchial obstruction and Asthma (COBRA) is a longitudinal cohor...
BACKGROUND The UK Severe Asthma Registry (UKSAR) is the world's largest national severe asthma re...
BACKGROUND The UK Severe Asthma Registry (UKSAR) is the world's largest national severe asthma re...
BACKGROUND: Asthma is now widely recognised to be a heterogeneous disease. The last two decades have...
The WATCH Study is a longitudinal study of patients under the Difficult Asthma Clinic at University ...
Background: Currently, there are no studies of well-characterized severe asthmatics in Brazil. We ai...
Background: Currently, there are no studies of well-characterized severe asthmatics in Brazil. We ai...
Abstract: Background: Distinct asthma phenotypes have previously been suggested, including benign as...
BACKGROUND: Asthma is a diverse condition that differs with age and sex. However, it remains unclear...
Background: Severe asthma is a complex amalgam of phenotypes and comorbidities. Most novel therapies...
WATCH is a longitudinal observational study of patients under the Difficult Asthma Clinic at Univers...
Francis Nissen,1 Ian J Douglas,1 Hana Müllerová,2 Neil Pearce,1 Chloe I Bloom,3 Liam Sme...
Background Severe and difficult to treat asthma impairs health status and accounts for about half of...
Background: Clinical characteristics of the international population with severe asthma are unknown....
Background: Clinical characteristics of the international population with severe asthma are unknown....
International audienceThe COhort of BRonchial obstruction and Asthma (COBRA) is a longitudinal cohor...
BACKGROUND The UK Severe Asthma Registry (UKSAR) is the world's largest national severe asthma re...
BACKGROUND The UK Severe Asthma Registry (UKSAR) is the world's largest national severe asthma re...
BACKGROUND: Asthma is now widely recognised to be a heterogeneous disease. The last two decades have...
The WATCH Study is a longitudinal study of patients under the Difficult Asthma Clinic at University ...
Background: Currently, there are no studies of well-characterized severe asthmatics in Brazil. We ai...
Background: Currently, there are no studies of well-characterized severe asthmatics in Brazil. We ai...
Abstract: Background: Distinct asthma phenotypes have previously been suggested, including benign as...
BACKGROUND: Asthma is a diverse condition that differs with age and sex. However, it remains unclear...
Background: Severe asthma is a complex amalgam of phenotypes and comorbidities. Most novel therapies...
WATCH is a longitudinal observational study of patients under the Difficult Asthma Clinic at Univers...
Francis Nissen,1 Ian J Douglas,1 Hana Müllerová,2 Neil Pearce,1 Chloe I Bloom,3 Liam Sme...
Background Severe and difficult to treat asthma impairs health status and accounts for about half of...
Background: Clinical characteristics of the international population with severe asthma are unknown....
Background: Clinical characteristics of the international population with severe asthma are unknown....
International audienceThe COhort of BRonchial obstruction and Asthma (COBRA) is a longitudinal cohor...
BACKGROUND The UK Severe Asthma Registry (UKSAR) is the world's largest national severe asthma re...
BACKGROUND The UK Severe Asthma Registry (UKSAR) is the world's largest national severe asthma re...